Two-Dose Hepatitis A Revaccination Schedule Optimal for Patients With HIV
Researchers evaluated the optimal timing for vasopressin initiation for reducing the risk of mortality among patients with septic shock.
Hepatology Information Center
Injection Drug Use-Associated HIV, HCV Risk Higher in Women, Younger Individuals
Researchers evaluated global data on HIV infection and primary hepatic C virus infection incidence among injections drug users.
Men Break Too: Recognizing the Role of Liver Disease in Osteoporosis
Nonalcoholic fatty liver disease and alcoholic liver disease are underrecognized causes of osteoporosis in men.
Point-of-Care HCV Testing Improves Treatment Uptake, Time to Initiation
Researchers compared hepatitis C virus point-of-care RNA viral load testing with laboratory-based testing to determine the effects on treatment uptake and turnaround times.
Managing Hepatitis C in Treatment-Naïve Patients With HIV Coinfection
Studies show that mortality, morbidity, and hepatic decompensation risks increase with coinfection of HIV and HCV, indicating that adequate and efficient treatment must be provided for both viruses.
Liver May Be Reservoir for HIV DNA in Patients With HBV Coinfection on ART
Researchers evaluated whether HIV DNA persists in the liver among individuals receiving suppressive antiretroviral therapy.
HIV Serostatus Affects Hepatitis C Virus Care Cascade
Researchers sought to evaluate differences in immunologic markers between those with HIV and those at risk for HIV with opioid use disorder.
NPs, PAs Needed to Treat Growing Rates of Liver Disease
Liver disease and cirrhosis now outpace diabetes and stroke as the leading cause of mortality in people aged 25 to 54 years. New survey results shows shortfalls in adoption of national treatment guidelines for liver disease and cirrhosis.
HepB-CpG Vaccination Achieves Maximum Seroprotection in Patients With HIV
Researchers evaluated patients with HIV infection who received the HepB-CpG vaccine, a hepatitis B surface antigen vaccine adjuvanted with a toll-like receptor 9 agonist.
How Can Hepatitis Vaccination Adherence Be Improved for At-Risk Adults?
Adults at risk of hepatitis A and hepatitis B have multi-dose vaccinations available, but complete and timely vaccination adherence rates are low. What can be done to encourage more vaccine adherence?
Treatment for Hepatitis C Up Among People Who Inject Drugs
Among persons who inject drugs with chronic HCV infection, proportion with detectable HCV RNA decreased from 100% in 2006 to 48% in 2019.
No Increase Seen in Pediatric Hepatitis in the United States
No increase in acute hepatitis of unspecified etiology, adenovirus types 40/41 above prepandemic baseline levels.
Mystery of Pediatric Hepatitis Cases Deepens as CDC Probe Continues
One more US death related to pediatric hepatitis was reported.
Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis.
Universal Hepatitis B Vaccination Recommended for Adults Aged 19 to 59 Years
CDC updates hepatitis B vaccination recommendation for adults
Testing, Treatment Initiations for Hepatitis C Decreased During the COVID-19 Pandemic
In this study, researchers assessed the nationwide rate of testing and treatment initiations for hepatitis C virus infection in the United States following the onset of the COVID-19 pandemic through the end of 2020.
Hepatitis C Virus Positivity Linked to Schizophrenia Development
Incidence of overall mortality was also highest for untreated patients with hepatitis C virus.
ACIP: 2022 Adult Immunization Schedule Updates
The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes.
High Immunogenicity Observed Among Healthy Adults After 3 Doses of the 3-Antigen Formulation Hepatitis B Vaccine
Investigators assessed the manufacturing consistency, safety, and efficacy of a 3-antigen hepatitis B vaccine vs a single-antigen formulation.
Regular Thyroid Screening Recommended for People With Hepatitis C
People with hepatitis C are at an increased risk for several autoimmune disorders. Researchers sought to discover a link between the virus and hypothyroidism.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hepatology Information Center
Loading... 
Loading...